BioSpace News Archive

Baudax Bio, Inc., a pharmaceutical company focused on therapeutics for acute care settings, provided an update regarding the initial commercial launch of ANJESO and provided an overview of other corporate initiatives and achievements.

Mereo BioPharma Group plc, a clinical stage biopharmaceutical company focused on oncology and rare diseases, announced the appointment of Christine Fox, CPA, as Chief Financial Officer and Heidi Petersen as Senior Vice President, Regulatory Affairs.

Phosplatin Therapeutics LLC announced that data revealing novel mechanistic attributes of its lead candidate PT-112, an immunogenic cell death inducer under Phase 2 development, will be presented at the 32nd Symposium of the European Organisation for Research and Treatment of Cancer, the National Cancer Institute and the American Association for Cancer Research taking place virtually from October 24-25.

Nevakar Inc. and Zhaoke Ophthalmology Pharmaceutical Ltd. announced that they have recently entered into an exclusive licensing agreement for the development and commercialization of Nevakar’s NVK-002 in Greater China, South Korea and the Southeast Asian territories.

JSR Life Sciences, LLC announced that it is increasing its European footprint with a newly expanded, state-of-the-art facility that will co-locate primary European operations for its affiliate companies KBI Biopharma and Selexis SA.

Biodesix, Inc. a leading data-driven diagnostic solutions company with a focus in lung disease, recently published data from three clinical studies, which found important new information on diagnosis and management of lung nodules.

Advancements in Technology and Patient Access Deliver Better Clinical Trial Access, Quality, and Experiences

Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on anti-infective drug development, today announced that investigators enrolled and dosed the first cluster of participants in Appili’s CONTROL COVID-19 clinical trial. Appili is sponsoring the Phase 2 cluster-randomized placebo-controlled trial (cluster-RCT

Home sleep screening devices are electronic devices used to monitor regularity of sleep. They can be used for personal use or for monitoring sleep of infants.

Transparency Market Research has published a new report titled, ‘Cardiopulmonary Stress Testing Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.